There was a big splash in the news recently about a study showing coffee drinking prevented cirrhosis. This seems to have struck a chord with people, and I’ve been getting...
Read More
By Peter G. Traber, M.D. on March 24, 2016 You may have seen Newsweek’s recent article on the growing impact of NASH, NASH Is the 21st Century’s Looming Health Threat....
Read More
By Peter G. Traber, M.D. on February 3, 2016 Are you one of the nearly 40% of Americans classified as obese or are you overweight and inexorably headed towards obesity? ...
Read More
By Peter G. Traber, M.D. on January 28, 2016 I wrote recently about why we rely on liver biopsies for the diagnosis of NASH and liver fibrosis and the need for...
Read More
By Peter G. Traber, M.D. on January 20, 2016 Several of my past CEO Perspectives have touched on the need for a non-invasive test in diagnosing and following treatment of fatty...
Read More
By Galectin Therapeutics. on January 7, 2016 The many accomplishments at Galectin Therapeutics during 2015 ranged from incremental progress touching every aspect of our business to significant advancements with GR-MD-02. Importantly,...
Read More Second Phase 2 clinical trial initiated for fatty liver disease with advanced fibrosis
0 Comments , in Article
Written by Peter G. Traber, M.D. on September 16, 2015 As a company, we are focused on developing a therapy for patients with non-alcoholic steatohepatitis (NASH), or fatty liver disease,...
Read More
Written by Peter G. Traber, M.D. on September 2, 2015 In late June 2015, Galectin Therapeutics initiated a Phase 2 clinical trial (the NASH-CX trial) to evaluate the ability of...
Read More
Written by Peter G. Traber, M.D. on August 17, 2015 Galectin Therapeutics is developing a drug called GR-MD-02 which binds to and inhibits the galectin-3 protein which is important in...
Read More The Potential for Treatment of Liver Fibrosis With Galectin’s Drug Candidate GR-MD-02
0 Comments , in Article
Written by Peter G. Traber, M.D. on July 31, 2015 Liver fibrosis is scar formation in the liver which, when it reaches a large amount of scar tissue (called cirrhosis),...
Read More